OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Validation of a diagnostic microRNA classifier in cutaneous T-cell lymphomas
Troels Marstrand, Charlotte B. Ahler, Ulrik Ralfkiær, et al.
Leukemia & lymphoma/Leukemia and lymphoma (2013) Vol. 55, Iss. 4, pp. 957-958
Closed Access | Times Cited: 31

Showing 1-25 of 31 citing articles:

Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma
Anita G. Seto, Xuan Beatty, Joshua M. Lynch, et al.
British Journal of Haematology (2018) Vol. 183, Iss. 3, pp. 428-444
Open Access | Times Cited: 248

Bacterial Toxins Fuel Disease Progression in Cutaneous T-Cell Lymphoma
Andreas Willerslev-Olsen, Thorbjørn Krejsgaard, Lise M. Lindahl, et al.
Toxins (2013) Vol. 5, Iss. 8, pp. 1402-1421
Open Access | Times Cited: 84

Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma
Nina A. Sibbesen, Katharina Kopp, Ivan V. Litvinov, et al.
Oncotarget (2015) Vol. 6, Iss. 24, pp. 20555-20569
Open Access | Times Cited: 82

MicroRNA Expression Profiling and DNA Methylation Signature for Deregulated MicroRNA in Cutaneous T-Cell Lymphoma
Juan Sandoval, Ángel Díaz‐Lagares, Rocío Salgado, et al.
Journal of Investigative Dermatology (2014) Vol. 135, Iss. 4, pp. 1128-1137
Open Access | Times Cited: 82

MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
Ulrik Ralfkiær, Lise M. Lindahl, Thomas Litman, et al.
PubMed (2014) Vol. 34, Iss. 12, pp. 7207-17
Closed Access | Times Cited: 70

STAT5 induces miR-21 expression in cutaneous T cell lymphoma
Lise M. Lindahl, Simon Fredholm, Claudine Joseph, et al.
Oncotarget (2016) Vol. 7, Iss. 29, pp. 45730-45744
Open Access | Times Cited: 49

MicroRNA Signatures in Diagnosis and Prognosis of Cutaneous T-Cell Lymphoma
Xiaoyan Shen, Bo Wang, Kejia Li, et al.
Journal of Investigative Dermatology (2018) Vol. 138, Iss. 9, pp. 2024-2032
Open Access | Times Cited: 46

MicroRNAs in the Pathogenesis, Diagnosis, Prognosis and Targeted Treatment of Cutaneous T-Cell Lymphomas
Maria Gluud, Andreas Willerslev-Olsen, Lise Mette Rahbek Gjerdrum, et al.
Cancers (2020) Vol. 12, Iss. 5, pp. 1229-1229
Open Access | Times Cited: 37

Diagnosis of Early Mycosis Fungoides
Tomomitsu Miyagaki
Diagnostics (2021) Vol. 11, Iss. 9, pp. 1721-1721
Open Access | Times Cited: 31

Plasma miR-155, miR-203, and miR-205 are Biomarkers for Monitoring of Primary Cutaneous T-Cell Lymphomas
Nina Dusílková, Petra Bašová, Jindřich Polívka, et al.
International Journal of Molecular Sciences (2017) Vol. 18, Iss. 10, pp. 2136-2136
Open Access | Times Cited: 34

Real-Life Barriers to Diagnosis of Early Mycosis Fungoides: An International Expert Panel Discussion
Emmilia Hodak, Larisa J. Geskin, Emmanuella Guenova, et al.
American Journal of Clinical Dermatology (2022) Vol. 24, Iss. 1, pp. 5-14
Open Access | Times Cited: 16

Diagnostic significance of dysregulated miRNAs in T-cell malignancies and their metabolic roles
Deepankar Mondal, Sapnita Shinde, Souvik Paul, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8

Expression of miR‐155 and miR‐126 in situ in cutaneous T‐cell lymphoma
Katharina Kopp, Ulrik Ralfkiær, Boye Schnack Nielsen, et al.
Apmis (2013) Vol. 121, Iss. 11, pp. 1020-1024
Closed Access | Times Cited: 28

miRNAs in inflammatory skin diseases and their clinical implications
Marianne B. Løvendorf, Lone Skov
Expert Review of Clinical Immunology (2015) Vol. 11, Iss. 4, pp. 467-477
Closed Access | Times Cited: 27

Dermal nanomedicine: Uncovering the ability of nucleic acid to alleviate autoimmune and other related skin disorders
Krishna Yadav, Deependra Singh, Manju Rawat Singh, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 73, pp. 103437-103437
Closed Access | Times Cited: 13

Epigenetics of cutaneous T-cell lymphoma: biomarkers and therapeutic potentials
Pan Lai, Yang Wang
Cancer Biology and Medicine (2021) Vol. 18, Iss. 1, pp. 34-51
Open Access | Times Cited: 16

Mycosis fungoides progression could be regulated by microRNAs
Rebeca Manso, Nerea Martı́nez, Itziar Eraña‐Tomás, et al.
PLoS ONE (2018) Vol. 13, Iss. 6, pp. e0198477-e0198477
Open Access | Times Cited: 19

Diagnosis, prognosis and management of erythrodermic cutaneous T-cell lymphoma
B. Moriarty, Sean Whittaker
Expert Review of Hematology (2014) Vol. 8, Iss. 2, pp. 159-171
Closed Access | Times Cited: 12

miR-155 meets the JAK/STAT pathway
Jenny L. Persson
Cell Cycle (2013) Vol. 12, Iss. 14, pp. 2170-2170
Open Access | Times Cited: 12

miRNA in mycosis fungoides and skin inflammation
Jenny L. Persson
Apmis (2013) Vol. 121, Iss. 11, pp. 1017-1019
Closed Access | Times Cited: 11

MicroRNA Expression Profile Differs Between Erythrodermic Mycosis Fungoides and Sézary Syndrome
A. Rittig, Lise M. Lindahl, Claus Johansen, et al.
Acta Dermato Venereologica (2019)
Open Access | Times Cited: 8

Unilesional mycosis fungoides is associated with increased expression of micro RNA ‐17~92 and T helper 1 skewing
Lilach Moyal, Batia Gorovitz-Haris, Shiran Yehezkel, et al.
British Journal of Dermatology (2018) Vol. 180, Iss. 5, pp. 1123-1134
Closed Access | Times Cited: 7

Page 1 - Next Page

Scroll to top